Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix

Pathologie Biologie

Volumn 60, Issue 3, 2012, Pages 199-207

  Demoor, M ^a   Maneix, L ^a   Ollitrault, D ^a   Legendre, F ^a   Duval, E ^a   Claus, S ^b   Mallein Gerin, F ^b   Moslemi, S ^a   Boumediene, K ^a   Galera, P ^a  

^a Biology and Innovative Therapeutics for Ovarian Cancers group   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Autologous transplantation; Chondrocytes; Differentiation; Extracellular matrix; Hyaline cartilage; Regenerative medicine; Type II collagen

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; INTERLEUKIN 6; POLYGLACTIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AUTOTRANSPLANTATION; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; COL2A1 GENE; DEPOLYMERIZATION; EXTRACELLULAR MATRIX; GENE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HYALINE CARTILAGE; INTRON; OSTEOARTHRITIS; PHENOTYPE; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW; RNA SPLICING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE REPAIR; TRANSCRIPTION REGULATION;

CARTILAGE; CHONDROCYTES; HUMANS; HYALIN; HYALINE CARTILAGE; MODELS, BIOLOGICAL; REGENERATION; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84861655273     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2012.03.003     Document Type: Review

References (66)

1. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331(14):889-895.
2. Galois L., Freyria A., Herbage D., Mainard D. Cartilage tissue engineering: state-of-the-art and future approaches. Pathol Biol 2005, 53(10):590-598.
3. Salentey V., Claus S., Bougault C., Paumier A., Aubert-Foucher E., Perrier-Groult E., et al. Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: potential use of bone morphogenetic protein-2 for cartilage cell therapy. Pathol Biol 2009, 57(4):282-289.
4. Knutsen G., Drogset J.O., Engebretsen L., Grøntvedt T., Isaksen V., Ludvigsen T.C., et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007, 89(10):2105-2112.
5. Frenkel S.R., Di Cesare P.E. Degradation and repair of articular cartilage. Front Biosci 1999, 4:D671-D685.
6. Clouet J., Vinatier C., Merceron C., Pot-vaucel M., Maugars Y., Weiss P., et al. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today 2009, 14519-20:913-925.
7. Peterson L., Vasiliadis H.S., Brittberg M., Lindahl A. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 2010, 38(6):1117-1124.
8. Harris J.D., Siston R.A., Pan X., Flanigan D.C. Autologous chondrocyte implantation: a systematic review. J Bone Joint Surg Am 2010, 92(12):2220-2233.
9. Harris J.D., Siston R.A., Brophy R.H., Lattermann C., Carey J.L., Flanigan D.C. Failures, re-operations, and complications after autologous chondrocyte implantation - a systematic review. Osteoarthr Cartil 2011, 19(7):779-791.
10. Roberts S., McCall I.W., Darby A.J., Menage J., Evans H., Harrison P.E., et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther 2003, 5(1):R60-R73.
11. Tins B.J., McCall I.W., Takahashi T., Cassar-Pullicino V., Roberts S., Ashton B., et al. Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up. Radiology 2005, 234(2):501-508.
12. Bartlett W., Skinner J.A., Gooding C.R., Carrington R.W.J., Flanagan A.M., Briggs T.W.R., et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br 2005, 87(5):640-645.
13. Behrens P., Bitter T., Kurz B., Russlies M. Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI) - 5-year follow-up. Knee 2006, 13(3):194-202.
14. Giza E., Sullivan M., Ocel D., Lundeen G., Mitchell M.E., Veris L., et al. Matrix-induced autologous chondrocyte implantation of talus articular defects. Foot Ankle Int 2010, 31(9):747-753.
15. Demoor-Fossard M., Boittin M., Rédini F., Pujol J. Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers. Mol Cell Biochem 1999, 199(1-2):69-80.
16. Kumar D., Lassar A.B. The transcriptional activity of Sox9 in chondrocytes is regulated by RhoA signaling and actin polymerization. Mol Cell Biol 2009, 29(15):4262-4273.
17. Gavenis K., Schmidt-Rohlfing B., Mueller-Rath R., Andereya S., Schneider U. In vitro comparison of six different matrix systems for the cultivation of human chondrocytes. In Vitro Cell Dev Biol Anim 2006, 42(5-6):159-167.
18. Mueller-Rath R., Gavenis K., Andereya S., Mumme T., Albrand M., Stoffel M., et al. Condensed cellular seeded collagen gel as an improved biomaterial for tissue engineering of articular cartilage. Biomed Mater Eng 2010, 20(6):317-328.
19. Eyre D.R., Weis M.A., Wu J. Articular cartilage collagen: an irreplaceable framework?. Eur Cell Mater 2006, 12:57-63.
20. Sandberg M.M., Hirvonen H.E., Elima K.J., Vuorio E.I. Co-expression of collagens II and XI and alternative splicing of exon 2 of collagen II in several developing human tissues. Biochem J 1993, 294(Pt 2):595-602.
21. McAlinden A., Johnstone B., Kollar J., Kazmi N., Hering T.M. Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation. Matrix Biol 2008, 27(3):254-266.
22. Sandell L.J., Morris N., Robbins J.R., Goldring M.B. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 1991, 114(6):1307-1319.
23. Lui V.C., Ng L.J., Nicholls J., Tam P.P., Cheah K.S. Tissue-specific and differential expression of alternatively spliced alpha 1(II) collagen mRNAs in early human embryos. Dev Dyn 1995, 203(2):198-211.
24. Aigner T., Zhu Y., Chansky H.H., Matsen F.A., Maloney W.J., Sandell L.J. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 1999, 42(7):1443-1450.
25. Zhu Y., Oganesian A., Keene D.R., Sandell L.J., Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol 1999, 144(5):1069-1080.
26. McAlinden A., Havlioglu N., Liang L., Davies S.R., Sandell L.J. Alternative splicing of type II procollagen exon 2 is regulated by the combination of a weak 5' splice site and an adjacent intronic stem-loop cis element. J Biol Chem 2005, 280(38):32700-32711.
27. Ghayor C., Chadjichristos C., Herrouin J.F., Ala-Kokko L., Suske G., Pujol J., et al. Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J Biol Chem 2001, 276(40):36881-36895.
28. Kypriotou M., Beauchef G., Chadjichristos C., Widom R., Renard E., Jimenez S.A., et al. Human collagen Krox up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors. J Biol Chem 2007, 282(44):32000-32014.
29. Pujol J., Loyau G. Interleukin-1 and osteoarthritis. Life Sci 1987, 41(10):1187-1198.
30. Pelletier J.P., Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol Suppl 1989, 18:19-27.
31. Chadjichristos C., Ghayor C., Herrouin J., Ala-Kokko L., Suske G., Pujol J., et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem 2002, 277(46):43903-43917.
32. Chadjichristos C., Ghayor C., Kypriotou M., Martin G., Renard E., Ala-Kokko L., et al. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem 2003, 278(41):39762-39772.
33. Porée B., Kypriotou M., Chadjichristos C., Beauchef G., Renard E., Legendre F., et al. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem 2008, 283(8):4850-4865.
34. Ghayor C., Herrouin J.F., Chadjichristos C., Ala-Kokko L., Takigawa M., Pujol J., et al. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem 2000, 275(35):27421-27438.
35. Kypriotou M., Fossard-Demoor M., Chadjichristos C., Ghayor C., de Crombrugghe B., Pujol J., et al. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol 2003, 22(2):119-129.
36. Zhou G., Garofalo S., Mukhopadhyay K., Lefebvre V., Smith C.N., Eberspaecher H., et al. A 182bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J Cell Sci 1995, 108(Pt 12):3677-3684.
37. Lefebvre V., Mukhopadhyay K., Zhou G., Garofalo S., Smith C., Eberspaecher H., et al. A 47-bp sequence of the first intron of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte Expression. Ann N Y Acad Sci 1996, 785:284-287.
38. Zhou G., Lefebvre V., Zhang Z., Eberspaecher H., de Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 1998, 273(24):14989-14997.
39. Lefebvre V., Li P., de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 1998, 17(19):5718-5733.
40. Lefebvre V. Toward understanding the functions of the two highly related Sox5 and Sox6 genes. J Bone Miner Metab 2002, 20(3):121-130.
41. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000, 275(15):10738-10744.
42. Haag J., Gebhard P.M., Aigner T. SOX gene expression in human osteoarthritic cartilage. Pathobiology 2008, 75(3):195-199.
43. Murakami S., Lefebvre V., de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 2000, 275(5):3687-3692.
44. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 1999, 22(1):85-89.
45. Bridgewater L.C., Lefebvre V., de Crombrugghe B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 1998, 273(24):14998-15006.
46. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997, 16(2):174-178.
47. Savagner P., Krebsbach P.H., Hatano O., Miyashita T., Liebman J., Yamada Y. Collagen II promoter and enhancer interact synergistically through Sp1 and distinct nuclear factors. DNA Cell Biol 1995, 14(6):501-510.
48. Leung K.K, Ng L.J., Ho K.K., Tam P.P., Cheah K.S. Different cis-regulatory DNA elements mediate developmental stage-and tissue-specific expression of the human COL2A1 gene in transgenic mice. J Cell Biol 1998, 141(6):1291-1300.
49. Renard E, Porée B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, et al. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl) 2012 Jan 4, doi:10.1007/s00109-011-0842-3.
50. Lefebvre V., Behringer R.R., de Crombrugghe B. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthr Cartil 2001, 9(Suppl A):S69-S75.
51. Hautier A., Salentey V., Aubert-Foucher E., Bougault C., Beauchef G., Ronzière M., et al. Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro. Growth Factors 2008, 26(4):201-211.
52. Maneix L, Boujrad N, Flouriot G, Demoor M, Boumédiene K, Galéra P. 17β-estradiol-induced up-regulation of type II collagen expression is mediated by ERα/Sp/SOX9/p300 complex through COL2A1 promoter/first intron interactions in differentiated and dedifferentiated articular chondrocytes. Brussels, Belgium: 2010 World Congress on osteoarthritis, OARSI; 2010.
53. Claus S., Aubert-Foucher E., Demoor M., Camuzeaux B., Paumier A., Piperno M., et al. Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures. J Cell Biochem 2010, 111(6):1642-1651.
54. Duval E., Leclercq S., Elissalde J., Demoor M., Galéra P., Boumédiene K. Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes. Arthritis Rheum 2009, 60(10):3038-3048.
55. Betre H., Ong S.R., Guilak F., Chilkoti A., Fermor B., Setton L.A. Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials 2006, 27(1):91-99.
56. Hirao M., Tamai N., Tsumaki N., Yoshikawa H., Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006, 281(41):31079-31092.
57. Claus S., Aubert-Foucher E., Perrier-Groult E., Bougault C., Ronzière M., Freyria A., et al. Décryptage des signalisations moléculaires contrôlant la différenciation des chondrocytes : retombées pour l'ingénierie tissulaire du cartilage : le projet ANR-TecSan PROMOCART. IRBM 2011, 32(2):95-98.
58. Benya P.D., Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982, 30(1):215-224.
59. Stokes D.G., Liu G., Dharmavaram R., Hawkins D., Piera-Velazquez S., Jimenez S.A. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J 2001, 360(Pt 2):461-470.
60. Kouri J.B., Lavalle C. Do chondrocytes undergo "activation" and "transdifferentiation" during the pathogenesis of osteoarthritis? A review of the ultrastructural and immunohistochemical evidence. Histol Histopathol 2006, 21(7):793-802.
61. Doré S., Pelletier J.P., DiBattista J.A., Tardif G., Brazeau P., Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. Arthritis Rheum 1994, 37(2):253-263.
62. Valcourt U., Gouttenoire J., Aubert-Foucher E., Herbage D., Mallein-Gerin F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 2003, 545(2-3):115-119.
63. Beauchef G, Bigot N, Kypriotou M, Renard E, Porée B, Moslemi S, et al. The p65 subunit of NF-kB inhibits COL1A1 gene transcription in human dermal fibroblasts through protein interaction with hc-Krox, Sp1 and Sp3. Atlanta, Georgia, USA: 71st Society for Investigative Dermatology Annual Meeting; 2010.
64. Allebach E.S., Boettiger D., Pacifici M., Adams S.L. Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation. Mol Cell Biol 1985, 5(5):1002-1008.
65. Saxe S.A., Lukens L.N., Pawlowski P.J. Changes in the nuclear and cytoplasmic levels of type I and type II collagen RNAs during growth of chondrocytes in 5-bromo-2'-deoxyuridine. J Biol Chem 1985, 260(6):3812-3819.
66. Farrell C.M., Lukens L.N. Naturally occurring antisense transcripts are present in chick embryo chondrocytes simultaneously with the down-regulation of the alpha 1 (I) collagen gene. J Biol Chem 1995, 270(7):3400-3408.